Prognostic Factors in Patients with Advanced Lung Adenocarcinoma Treated with Icotinib

Objective To investigate the relationship between the treatment of EGFR-TKI icotinib and the prognosis of advanced lung adenocarcinoma patients with EGFR mutation. Methods Patients with advanced lung adenocarcinoma who had EGFR19 and 21 gene mutations and were treated with EGFR-TKI icotinib were enr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	ZHANG Hongbin, ZHU Lingling, XIE Jiong, CAI Hongmei, JI Qiaoxia, LIANG Xiangcun, LI Hua, WANG Yuan, ZHAO Min
Formatua:	Artigo
Hizkuntza:	Chinês
Argitaratua:	Magazine House of Cancer Research on Prevention and Treatment 2022-11-01
Saila:	Zhongliu Fangzhi Yanjiu
Gaiak:	lung cancer egfr tki icotinib neoplasm metastasis
Sarrera elektronikoa:	http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0174
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!